Cover Image
市場調查報告書

經導管二尖瓣置換的全球市場:2016∼2020年

Global Transcatheter Mitral Valve Replacement Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 364918
出版日期 內容資訊 英文 46 Pages
訂單完成後即時交付
價格
Back to Top
經導管二尖瓣置換的全球市場:2016∼2020年 Global Transcatheter Mitral Valve Replacement Market 2016-2020
出版日期: 2016年07月19日 內容資訊: 英文 46 Pages
簡介

二尖瓣管理從左心房到左心室血流。二尖瓣逆流是常見二尖瓣的疾病,心外科醫生進行手術或經導管置換二尖瓣。全球經導管二尖瓣置換市場,預計2016∼2020年以21.93%的年複合成長率擴大。

本報告提供全球經導管二尖瓣置換市場相關調查,市場成長預測,各地區趨勢,市場趨勢與課題,主要供應商的競爭趨勢等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

第5章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第6章 經導管二尖瓣置換的全球市場:各產品市場分類

  • 經大腿植入
  • 經心尖植入

第7章 美國的經導管二尖瓣置換的償付和經濟

  • 償付趨勢
  • 經濟影響

第8章 經導管二尖瓣置換的全球市場:各地區分類

  • 南北美洲
  • 歐洲、中東、非洲
  • 亞太地區

第9章 經導管二尖瓣置換的全球市場:促進要素

  • 二尖瓣逆流的罹患率
  • 微創手術的使用
  • 高風險患者的經導管二尖瓣置換的使用

第10章 促進要素的影響

第11章 經導管二尖瓣置換的全球市場:課題

  • 替代治療的取得
  • 嚴厲的法律規章
  • 熟練人員的不足

第12章 促進要素與課題的影響

第13章 經導管二尖瓣置換的全球市場:趨勢

第14章 供應商環境

  • 競爭模式
  • 產品系列矩陣

第15章 主要供應商分析

  • Abbott Laboratories
  • Edwards Lifesciences
  • Micro Interventional Devices
  • Neovasc
  • 其他值得注意的供應商

第16章 附錄

第17章 關於Technavio

目錄
Product Code: IRTNTR8929

About Mitral Valve

The mitral valve manages blood flow from the left atrium to the left ventricle. The valve prevents the backward flow of the blood. Mitral regurgitation is a common mitral valve disorder that causes the abnormal backward flow of the blood. Cardiologists use mitral surgical valve repair procedures or transcatheter replacement procedures to treat this disorder. About 80,000 individuals undergo these two procedures for treating the disorder.

Technavio's analysts forecast the global transcatheter mitral valve replacement market to grow at a CAGR of 21.93% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global transcatheter mitral valve replacement market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of transcatheter mitral valve implants.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Transcatheter Mitral Valve Replacement Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott Laboratories
  • Edwards Lifesciences
  • Micro Interventional Devices
  • Neovasc

Other Prominent Vendors

  • MitrAssist
  • NaviGate Cardiac Structures
  • Valtech
  • Boston Scientific
  • Medtronic

Market driver

  • Use of minimally invasive procedures
  • For a full, detailed list, view our report

Market challenge

  • Stringent regulatory framework
  • For a full, detailed list, view our report

Market trend

  • Increase in M&A
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Market segmentation by product

  • Transfemoral implantation
  • Transapical implantation

PART 07: Reimbursement and economics of transcatheter mitral valve replacement in US

  • Reimbursement for transcatheter mitral valve replacement
  • Economic impact of transcatheter mitral valve replacement

PART 08: Geographical segmentation

  • Transcatheter mitral valve replacement market in Americas
  • Transcatheter mitral valve replacement market in EMEA
  • Transcatheter mitral valve replacement market in APAC

PART 09: Market drivers

  • Prevalence of mitral regurgitation
  • Use of minimally invasive procedures
  • Use of transcatheter mitral valve replacement in high-risk individuals

PART 10: Impact of drivers

PART 11: Market challenges

  • Availability of alternative treatment
  • Stringent regulatory framework
  • Lack of skilled personnel

PART 12: Impact of drivers and challenges

PART 13: Market trends

  • Development of novel products
  • Increase in M&A
  • Focus on US

PART 14: Vendor landscape

  • Competitive scenario
  • Product portfolio matrix

PART 15: Key vendor analysis

  • Abbott Laboratories
  • Edwards Lifesciences
  • Micro Interventional Devices
  • Neovasc
  • Other prominent vendors

PART 16: Appendix

  • List of abbreviations

PART 17: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Global transcatheter mitral valve replacement market 2015-2020 ($ billions)
  • Exhibit 03: Five forces analysis
  • Exhibit 04: Global transcatheter mitral valve replacement market segmentation by product
  • Exhibit 05: Comparison of transfemoral and transapical implantation
  • Exhibit 06: Global transcatheter mitral valve replacement market segmentation by geography 2015
  • Exhibit 07: Global transcatheter mitral valve replacement market segmentation by geography 2020
  • Exhibit 08: Global transcatheter mitral valve replacement market segmentation by geography 2015-2020
  • Exhibit 09: Transcatheter mitral valve replacement market in Americas 2015-2020 ($ millions)
  • Exhibit 10: Transcatheter mitral valve replacement market in EMEA 2015-2020 ($ millions)
  • Exhibit 11: Transcatheter mitral valve replacement market in APAC 2015-2020 ($ millions)
  • Exhibit 12: Impact of drivers
  • Exhibit 13: Impact of drivers and challenges
  • Exhibit 14: Major acquisitions 2015
  • Exhibit 15: Products of few vendors 2015
  • Exhibit 16: Abbott Laboratories: Key takeaways
  • Exhibit 17: Edwards Lifesciences: Business segmentation by revenue 2014
  • Exhibit 18: Edwards Lifesciences: Business segmentation by revenue 2013 and 2014 ($ billions)
  • Exhibit 19: Edwards Lifesciences: Key takeaways
  • Exhibit 20: Micro Interventional Devices: Key takeaways
  • Exhibit 21: Neovasc: Geographical segmentation by revenue 2014
  • Exhibit 22: Neovasc: Key takeaways
  • Exhibit 23: Other vendors
  • Exhibit 24: Emerging vendors
Back to Top